SEC Form 4 · accession 0000721371-17-000035
CARDINAL HEALTH INC · CAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon L Giacomin
Officer — CEO, Pharmaceutical Segment
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000721371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | May 12, 2017 | M | 23,270 | $41.60 | A | 55,440 | D | |
| Common SharesF1 | May 12, 2017 | S | 23,270 | $72.87 | D | 32,170 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $41.60 | May 12, 2017 | M | 23,270 | D | — | Aug 15, 2021 | Common Shares | 23,270 | 0 | D |
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.81 to $72.91, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
- F2The option, representing a right to purchase a total of 23,270 shares, vested and became exercisable in three equal annual installments beginning on August 15, 2012.